In this review:
SGLT-2 inhibitors and GLP-1 agonists for type 2 diabetes
Access to publicly funded insulin pumps for type 1 diabetes in NZ
Impact of type 2 diabetes diagnosis age on mortality/vascular complications
Low- and very low-carbohydrate diets for type 2 diabetes remission
Metabolic surgery vs. medical therapy in type 2 diabetes
Comparison of two hybrid closedloop systems for type 1 diabetes
Impact of bariatric surgery on incident microvascular complications in type 2 diabetes
Time in glucose range and all-cause/CV mortality in type 2 diabetes
Physical activity for preventing type 2 diabetes
Real-world cardioprotective glucose-lowering drug use in type 2 diabetes + CV disease
Triple vs. stepwise addition therapy in new-onset type 2 diabetes
Impact of pharmacological and lifestyle interventions on bodyweight in type 1 diabetes
Impact of maternal obesity and inflammatory markers in breastmilk on infant growth
Risks of and risk factors for COVID-19 among diabetics
Please login below to download this issue (PDF)